IRIS - Res&Arch Institutional Research Information System - Research & Archive

FRANCISCI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.546
EU - Europa 5.604
AS - Asia 1.733
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 8
AF - Africa 3
OC - Oceania 1
Totale 13.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.520
IE - Irlanda 1.432
UA - Ucraina 978
IT - Italia 948
SE - Svezia 881
HK - Hong Kong 533
SG - Singapore 496
VN - Vietnam 317
FI - Finlandia 292
RU - Federazione Russa 286
CN - Cina 253
DE - Germania 249
GB - Regno Unito 154
FR - Francia 137
AT - Austria 52
CH - Svizzera 46
TR - Turchia 46
BE - Belgio 37
KR - Corea 30
PL - Polonia 29
NL - Olanda 28
UZ - Uzbekistan 26
CA - Canada 17
CZ - Repubblica Ceca 17
EU - Europa 12
GR - Grecia 12
LB - Libano 9
RO - Romania 9
MX - Messico 8
ES - Italia 6
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
ID - Indonesia 3
IL - Israele 3
IN - India 3
IR - Iran 3
BG - Bulgaria 2
BR - Brasile 2
CL - Cile 2
JP - Giappone 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
CO - Colombia 1
DK - Danimarca 1
GH - Ghana 1
IQ - Iraq 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 13.908
Salva come PNG Salva come JPEG
Città #
Dublin 1.430
Chandler 1.242
San Mateo 734
Hong Kong 529
Jacksonville 480
Altamura 407
Medford 372
Princeton 371
Dong Ket 316
Lawrence 300
Singapore 291
Wilmington 271
Perugia 248
Ann Arbor 240
Andover 227
Des Moines 129
Saint Petersburg 96
Dearborn 93
Ashburn 86
Beijing 82
Redmond 77
Norwalk 74
Falls Church 69
Woodbridge 68
San Paolo di Civitate 58
Boardman 56
Los Angeles 54
Helsinki 47
Izmir 43
Shanghai 38
Houston 37
Brussels 36
New York 34
Seoul 29
Redwood City 26
Philadelphia 24
Den Haag 23
Moscow 23
Vienna 21
Frankfurt Am Main 16
Rome 15
Auburn Hills 14
Florence 12
Chicago 11
Lappeenranta 11
Milan 10
Nanning 10
Ottawa 10
San Diego 10
Timisoara 9
Bastia umbra 8
Seattle 8
Cambridge 7
Lausanne 7
Nanjing 6
Olomouc 6
Tappahannock 6
Zhengzhou 6
Brno 5
Foligno 5
Kiev 5
Kunming 5
Paris 5
Piediluco 5
Toronto 5
Amelia 4
Amsterdam 4
Bologna 4
Bratislava 4
Clifton 4
Collazzone 4
Fairfield 4
Hefei 4
Inwood 4
Jinan 4
Ningbo 4
Pesaro 4
Santa Clara 4
Brescia 3
Catanzaro 3
Detroit 3
Edinburgh 3
Giugliano In Campania 3
Kocaeli 3
Kraków 3
London 3
Ludwigshafen 3
Menlo Park 3
Nagold 3
Nanchang 3
Napoli 3
Padova 3
Terni 3
Warsaw 3
Bari 2
Barletta 2
Blanes 2
Busto Arsizio 2
Calenzano 2
Charlotte 2
Totale 9.110
Salva come PNG Salva come JPEG
Nome #
Amfotericina B in complessi lipidici nel trattamento della Leishmaniosi viscerale in un paziente immunodepresso 93
Concentrazioni ossee e plasmatiche di moxifloxacina in pazienti operati di protesi di ginocchio 91
A case of severe cdfepime-related neutropenia in a 15-year-old patient 87
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 85
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 84
Nocardiosi cerebrale primaria in un paziente immunocompetente 83
Mielite da Toxoplasma gondii in un paziente con AIDS 82
Daily bathing with 4% chlorhexidine gluconate in intensive care settings: a randomized controlled trial 82
Trattamento dell'epatite cronica C con IFN-2b e ribavirina in pazienti non responder o relapser a solo IFN-: dati preliminari sulla nostra esperienza. 81
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 81
Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of healthcare workers. 80
Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study 79
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 79
L'infezione da Clostridium Difficile in pazienti ospedalizzati: uno studio retrospettivo. XXIX Congresso AMCLI 2000, 78
Encefalite emorragica e infezione disseminata da Epstein barr virus: descrizione di un caso clinico con outcome fatale. 77
Risk factors for acute parenterally transmitted viral hepatitis: a 20-year study. 77
A randomized trial comparing the introduction of ritonavir on indinavir in 1251 nucleoside-experienced patients with advanced HIV infection 76
Prima indagine sieroepidemiologica sulla circolazione del virus Toscana in Umbria. Atti congresso di malattie Infettive 75
Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man 75
Malattie Infettive trasmesse da Zecca in Umbria: indagine epidemiologica 74
Target di autoimmunità endocrina in corso di terapia con IFN-alfa in pazienti con epatite cronica da HCV. 30°congr.naz. SISMIP, Ferrara 6-9 ottobre 1999 74
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 74
Long term treatment of a variant form of autoimmune chronic active hepatitis with cyclosporine: a case report. 74
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 73
Tolerability of different postexposure prophylaxis regimens in occupational and non occupational exposures to HIV: the italian registry 72
Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. 71
Epidemiologia, clinica e terapia della coinfezione HIV-HCV nell'esperienza umbra. 67
Malattie da virus a DNA- Citomegalovirosi 67
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 67
epidemiologia e clinica della coinfezione HIV-HCV nell'esperienza umbra 66
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 66
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 66
Esperienza con Efavirenz nei pazienti con infezione da HIV seguiti presso la Clinica di Malattie Infettive di Perugia 64
Programmed granulocyte neutrophil death in patients at different stages of HIV infection 64
Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report 64
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 64
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 64
La terapia HAART nell'esperienza della clinica di Malattie Infettive di Perugia 63
Modificazioni epidemiologiche delle epatiti virali acute in Umbria; 30 anni di osservazione. Congresso Soc. It. Mal. Inf. 63
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 63
Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status. 63
Correlation of preS antigens and clinical status during chronic hepatitis B virus infection. 63
Anal Cancer Screening for Diagnosis and Treatment of Anal Squamous Intraepithelial Lesions in HIV-positive MSM patients 63
Effects of antiretroviral therapy on lipid and immunovirological profile: Focus on proprotein convertase subtilisin/kexin 9 63
Identificazione dei soggetti a più alto rischio di infezione disseminata da HCMV tra i riceventi un trapianto renale. 30° congr.naz. SISMIP Ferrara 6-9 ottobre 1999 62
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 62
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 62
Acute infection with parvovirus B19 manifesting as brain stem encephalitis. 62
A case of rhombencephalitis caused by Listeria monocytogenes successfully treated with linezolid 61
Infezioni da bacilli gram-negativi aerobi- Bartonellosi 61
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy. 60
Cytomegalovirus colitis in a patient with recent failure of kidney transplant. 60
Metodo rapido di estrazione dell'RNA da C. neoformans. 60
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder(INR) HIV-1-infected patients treated with HAART 60
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 60
ANALISI DELLA FUNZIONALITÀ RENALE IN PAZIENTI CON INFEZIONE DA HIV NAIVE TRATTATI CON TENOFOVIR. STUDIO CASO-CONTROLLO. 59
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression 59
HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy. 59
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 59
Patologie neurologiche AIDS-defining in era HAART e Pre-HAART: nuovi scenari 58
Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans 58
A nutraceutical combination targeting dyslipidemia and subclinical inflammation in HIV patients on stable antiretroviral therapy 58
Monitoraggio virologico dell'infezione da HCMV in pazienti riceventi trapianto di midollo osseo allogenico. 30°congr. Naz. SISMIP, Ferrara 6-9 ottobre 1999 58
Identification of a possible ancestor of the subtype A1 HIV Type 1 variant circulating in the former Soviet Union 58
Impact of Antimicrobial Stewardship Interventions on Appropriateness of Surgical Antibiotic Prophylaxis: How to Improve 58
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 58
Bone and serum concentrations of moxifloxacin in patients undergoing total knee arthroplasty 57
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virologiccal failure 57
Combined ganciclovir and foscarnet therapy of recurrent cytomegalovirus and aggressive retinitis in AIDS 57
Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty 57
Acute transverse myelitis and hepatitis C virus 55
Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS 55
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir,efavirenz or lopinavir/ritonavir in the Italian ARCA cohort 55
Suboptimal indinavir concentrations in cerebrospinal fluid 54
Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients. 54
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy 54
Antiretroviral drug susceptibility among drug-naive adults with chronic or recent HIV infectionin Umbria region 54
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013. 54
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 54
Alterazioni in HCMV end-organ disease in the course of highly active antiretroviral therapy (HAART). 54
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 54
Meningite cronica da HSV-2 in un adulto immunocompetente: descrizione di un caso clinco 53
Nitric oxide protects againist HIV gp 120 endothelial injury. 53
Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10 53
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 53
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 53
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 52
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 52
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 52
HIV-2 infection, end-stage renal disease and protease inhibitor intolerance, which salvage regimen? 52
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 52
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 52
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 51
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 51
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 50
L'utilizzo del test HIV-1-HIV2 rapido nella gestione delle esposizioni occupazionali negli operatori sanitari di Perugia 49
Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance theraphy 49
Evolution and predictors of HIV-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 49
Variazioni del cariotipo elettroforetico ed analisi RAPD di isolati clinici ed ambientali di C. neoformans. 49
Infezioni da bacilli gram-negativi aerobi- Infezioni da Helicobacter pylori 49
Totale 6.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.236 108 51 151 25 148 64 190 20 200 123 27 129
2020/20212.548 13 146 124 154 773 172 155 41 274 127 184 385
2021/20222.964 94 510 78 173 108 54 47 894 70 104 379 453
2022/20234.875 417 972 74 361 348 472 24 194 1.791 6 161 55
2023/20241.819 111 204 90 41 16 16 411 33 210 74 336 277
2024/202546 46 0 0 0 0 0 0 0 0 0 0 0
Totale 14.809